Home

Screening

Read time: 3 min

Congress highlights

Epigenetics – its putative role in psychiatric conditions, such as schizophrenia

Associations between prenatal stress and poor health, including poor mental wellbeing, later in...

Digital technologies - an opportunity to achieve Mental Health for All

Digital technologies have the potential to transform the theme for World Mental Health Day 2020...

Digital technologies — an opportunity to achieve Mental Health for All

Read time: 2 min

Digital technologies — an opportunity to achieve Mental Health for All

Digital technologies have the potential to transform the theme for World Mental Health Day 2020...

Read time: 3 min

The neurobiology of conversion to psychosis – emerging findings from the SHARP study

The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Two easy- and quick-to-administer techniques for detecting preclinical Alzheimer’s disease

Alzheimer’s disease (AD) is preceded by an asymptomatic (preclinical) phase that may last...

Read time: 3 min

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...

Read time: 5 min

Strategies for reducing the duration of untreated psychosis

Longer duration of untreated psychosis (DUP) is related to poor clinical and functional outcomes in...

Depression, Bipolar

Read time: 3 min

Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders

Brain health is important to us all, and cognitive impairment causes significant morbidity....

Depression, Bipolar

Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders

Read the full feature here. Download the audio file.

Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders

Read time: 4 min

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Alzheimer's Disease

Read time: 3 min

Talking about biomarker test results in Alzheimer’s disease

We still need to understand how disclosure of a positive biomarker test for Alzheimer’s...

Alzheimer's Disease

Read time: 3 min

Inside the black box: Unlocking the potential of big data in neurodegenerative diseases

Big data, artificial intelligence and machine learning offer huge opportunities for the collection...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country